Advertisement
U.S. Markets open in 8 hrs 58 mins

Star Fashion Culture Holdings Limited (STFS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
3.6200+0.0100 (+0.28%)
At close: 04:00PM EDT
3.5000 -0.12 (-3.31%)
After hours: 06:35PM EDT
Full screen
Loading interactive chart...
  • Business Wire

    WestPark Capital Announces Closing of $8.6 Million IPO for Star Fashion Culture Holdings Limited (NASDAQ:STFS)

    LOS ANGELES, October 16, 2024--WestPark Capital today announced the closing of an $8.6 million initial public offering for Star Fashion Culture Holdings Limited. The offering consisted of 2,150,000 Class A Ordinary Shares at a price of $4.00 per share to the public, for a total of approximately $8.6 million of gross proceeds to the Company, before deducting underwriting discounts and offering expenses. The shares began trading on the NASDAQ Capital Market on October 11, 2024, under the symbol "S

  • GlobeNewswire

    Star Fashion Culture Holdings Limited Announces Closing of $8.6 Million Initial Public Offering

    Xiamen, China, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Star Fashion Culture Holdings Limited (“Star Fashion” or “the Company”) today announced the closing of its previously announced initial public offering of an aggregate 2,150,000 Class A Ordinary Shares (“the Offering”) at a price of $4.00 per share (“the Offering Price”) to the public, for a total of approximately US$8.6 million of gross proceeds to the Company, before deducting underwriting discounts and offering expenses. The shares began tradin

  • TipRanks

    Opening Day: Another trio of biotech IPOs make Friday debut

    The Partners Group-backed KinderCare sold 24 million shares for $24 each this Tuesday. At the IPO price, the childhood education company had a market value of $2.74B, based on the outstanding shares. Sky Quarry, Click Holdings, and SKK Holdings also opened for trading this week. Meanwhile, a new trio of biotech companies’ shares came to market on Friday as Upstream Bio, Ceribell and Camp4 Therapeutics each made their public debut. In mid-September, Bicara Therapeutics (BCAX), MBX Biosciences (MB